KRAS and neoplasm: Although mutational spectra based on Kras and Hras proto-oncogenes will be biased because only some types of mutations at certain codons can result in an activated oncogene, nevertheless different agents induce mouse tumours with distinctly different patterns of mutations in these genes, which can be informative about mechanism of carcinogenesis and origins of tumours [6].